Market sentiment is cautious ahead of Budget 2026 due to global uncertainty and pre-Budget positioning. Experts suggest a continued capex push and targeted tax relief to boost disposable incomes and private investment. Investors are advised to focus on post-Budget clarity and earnings visibility, with a selective approach to small and midcap stocks.
Market bets on Aurobindo as Europe, US Sales show uptick
Aurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also developing weight loss